US Stock MarketDetailed Quotes

Krystal Biotech (KRYS)

Watchlist
  • 266.040
  • +3.780+1.44%
Close May 1 16:00 ET
  • 266.040
  • 0.0000.00%
Post 20:01 ET
7.83BMarket Cap38.89P/E (TTM)

Krystal Biotech (KRYS) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Total revenue
33.94%389.13M
17.52%107.11M
16.65%97.8M
36.65%96.04M
94.88%88.18M
473.02%290.52M
116.26%91.14M
879.91%83.84M
70.28M
45.25M
Operating revenue
33.94%389.13M
17.52%107.11M
16.65%97.8M
36.65%96.04M
94.88%88.18M
473.02%290.52M
116.26%91.14M
879.91%83.84M
--70.28M
--45.25M
Cost of revenue
14.89%23.05M
33.20%6.59M
-36.22%4.26M
19.24%7.17M
107.85%5.03M
548.38%20.06M
72.38%4.95M
2,897.31%6.68M
6.01M
2.42M
Gross profit
35.36%366.08M
16.62%100.51M
21.23%93.54M
38.28%88.88M
94.15%83.16M
468.12%270.45M
119.47%86.19M
825.92%77.16M
64.28M
42.83M
Operating expense
22.48%204.79M
25.50%56.24M
23.65%52.16M
14.72%49.57M
26.92%46.98M
15.54%167.21M
24.40%44.82M
22.90%42.19M
13.56%43.21M
1.91%37.02M
Selling and administrative expenses
29.14%146.74M
32.48%41.45M
31.06%37.58M
27.27%35.16M
25.58%32.72M
15.60%113.63M
26.91%31.29M
21.00%28.67M
6.65%27.63M
8.42%26.06M
Research and development costs
8.33%58.05M
9.36%14.79M
7.94%14.59M
-7.53%14.41M
30.10%14.26M
15.39%53.58M
18.96%13.53M
27.12%13.51M
28.32%15.58M
-10.83%10.96M
Operating profit
56.22%161.3M
7.00%44.27M
18.31%41.37M
86.59%39.31M
522.03%36.18M
206.31%103.25M
1,173.86%41.38M
234.54%34.97M
155.37%21.07M
116.01%5.82M
Net non-operating interest income expense
-4.84%28.18M
-5.17%6.86M
-9.65%6.59M
-0.15%7.47M
-2.57%7.42M
31.51%29.61M
-2.35%7.24M
8.26%7.3M
54.59%7.48M
116.00%7.62M
Non-operating interest income
-4.84%28.18M
-5.17%6.86M
-9.65%6.59M
-0.15%7.47M
----
31.51%29.61M
--7.24M
--7.3M
54.59%7.48M
116.00%7.62M
Total other finance cost
----
----
----
----
2.57%-7.42M
----
----
-8.84%-7.34M
----
---7.62M
Other net income (expense)
-142.86%-37.5M
0
-112.50%-12.5M
-12.5M
0.00%-12.5M
Special income (charges)
--0
--0
--0
--0
--0
-142.86%-37.5M
--0
-112.50%-12.5M
---12.5M
0.00%-12.5M
-Less:Other special charges
----
----
----
----
----
142.86%37.5M
--0
112.50%12.5M
--12.5M
0.00%12.5M
Income before tax
98.70%189.47M
5.19%51.13M
61.13%47.97M
191.52%46.78M
4,577.79%43.6M
639.37%95.36M
356.13%48.61M
-63.13%29.77M
148.31%16.05M
102.06%932K
Income tax
-347.86%-15.36M
-108.59%-269K
-1,312.75%-31.4M
1,669.81%8.44M
7.86M
215.37%6.2M
59.34%3.13M
2.59M
477K
0
Net income
129.74%204.83M
13.02%51.4M
192.00%79.37M
146.23%38.33M
3,734.01%35.73M
715.58%89.16M
423.23%45.48M
-66.34%27.18M
146.88%15.57M
102.06%932K
Net income continuous Operations
129.74%204.83M
13.02%51.4M
192.00%79.37M
146.23%38.33M
3,734.01%35.73M
715.58%89.16M
423.23%45.48M
-66.34%27.18M
146.88%15.57M
102.06%932K
Minority interest income
Net income attributable to the parent company
129.74%204.83M
13.02%51.4M
192.00%79.37M
146.23%38.33M
3,734.01%35.73M
715.58%89.16M
423.23%45.48M
-66.34%27.18M
146.88%15.57M
102.06%932K
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
129.74%204.83M
13.02%51.4M
192.00%79.37M
146.23%38.33M
3,734.01%35.73M
715.58%89.16M
423.23%45.48M
-66.34%27.18M
146.88%15.57M
102.06%932K
Basic earnings per share
126.92%7.08
12.03%1.77
188.42%2.74
146.30%1.33
4,033.33%1.24
680.00%3.12
393.75%1.58
-67.01%0.95
143.20%0.54
101.70%0.03
Diluted earnings per share
128.00%6.84
11.84%1.7
192.31%2.66
143.40%1.29
3,900.00%1.2
669.23%3
390.32%1.52
-67.38%0.91
142.40%0.53
101.70%0.03
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Total revenue 33.94%389.13M17.52%107.11M16.65%97.8M36.65%96.04M94.88%88.18M473.02%290.52M116.26%91.14M879.91%83.84M70.28M45.25M
Operating revenue 33.94%389.13M17.52%107.11M16.65%97.8M36.65%96.04M94.88%88.18M473.02%290.52M116.26%91.14M879.91%83.84M--70.28M--45.25M
Cost of revenue 14.89%23.05M33.20%6.59M-36.22%4.26M19.24%7.17M107.85%5.03M548.38%20.06M72.38%4.95M2,897.31%6.68M6.01M2.42M
Gross profit 35.36%366.08M16.62%100.51M21.23%93.54M38.28%88.88M94.15%83.16M468.12%270.45M119.47%86.19M825.92%77.16M64.28M42.83M
Operating expense 22.48%204.79M25.50%56.24M23.65%52.16M14.72%49.57M26.92%46.98M15.54%167.21M24.40%44.82M22.90%42.19M13.56%43.21M1.91%37.02M
Selling and administrative expenses 29.14%146.74M32.48%41.45M31.06%37.58M27.27%35.16M25.58%32.72M15.60%113.63M26.91%31.29M21.00%28.67M6.65%27.63M8.42%26.06M
Research and development costs 8.33%58.05M9.36%14.79M7.94%14.59M-7.53%14.41M30.10%14.26M15.39%53.58M18.96%13.53M27.12%13.51M28.32%15.58M-10.83%10.96M
Operating profit 56.22%161.3M7.00%44.27M18.31%41.37M86.59%39.31M522.03%36.18M206.31%103.25M1,173.86%41.38M234.54%34.97M155.37%21.07M116.01%5.82M
Net non-operating interest income expense -4.84%28.18M-5.17%6.86M-9.65%6.59M-0.15%7.47M-2.57%7.42M31.51%29.61M-2.35%7.24M8.26%7.3M54.59%7.48M116.00%7.62M
Non-operating interest income -4.84%28.18M-5.17%6.86M-9.65%6.59M-0.15%7.47M----31.51%29.61M--7.24M--7.3M54.59%7.48M116.00%7.62M
Total other finance cost ----------------2.57%-7.42M---------8.84%-7.34M-------7.62M
Other net income (expense) -142.86%-37.5M0-112.50%-12.5M-12.5M0.00%-12.5M
Special income (charges) --0--0--0--0--0-142.86%-37.5M--0-112.50%-12.5M---12.5M0.00%-12.5M
-Less:Other special charges --------------------142.86%37.5M--0112.50%12.5M--12.5M0.00%12.5M
Income before tax 98.70%189.47M5.19%51.13M61.13%47.97M191.52%46.78M4,577.79%43.6M639.37%95.36M356.13%48.61M-63.13%29.77M148.31%16.05M102.06%932K
Income tax -347.86%-15.36M-108.59%-269K-1,312.75%-31.4M1,669.81%8.44M7.86M215.37%6.2M59.34%3.13M2.59M477K0
Net income 129.74%204.83M13.02%51.4M192.00%79.37M146.23%38.33M3,734.01%35.73M715.58%89.16M423.23%45.48M-66.34%27.18M146.88%15.57M102.06%932K
Net income continuous Operations 129.74%204.83M13.02%51.4M192.00%79.37M146.23%38.33M3,734.01%35.73M715.58%89.16M423.23%45.48M-66.34%27.18M146.88%15.57M102.06%932K
Minority interest income
Net income attributable to the parent company 129.74%204.83M13.02%51.4M192.00%79.37M146.23%38.33M3,734.01%35.73M715.58%89.16M423.23%45.48M-66.34%27.18M146.88%15.57M102.06%932K
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 129.74%204.83M13.02%51.4M192.00%79.37M146.23%38.33M3,734.01%35.73M715.58%89.16M423.23%45.48M-66.34%27.18M146.88%15.57M102.06%932K
Basic earnings per share 126.92%7.0812.03%1.77188.42%2.74146.30%1.334,033.33%1.24680.00%3.12393.75%1.58-67.01%0.95143.20%0.54101.70%0.03
Diluted earnings per share 128.00%6.8411.84%1.7192.31%2.66143.40%1.293,900.00%1.2669.23%3390.32%1.52-67.38%0.91142.40%0.53101.70%0.03
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
On May 1, the more than two-month-long military conflict involving the US, Israel, and Iran will reach a legal milestone, potentially increa Show More